Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,540.00
Bid: 4,500.00
Ask: 4,540.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.889%)
Open: 4,580.00
High: 4,580.00
Low: 4,500.00
Prev. Close: 4,520.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Duncan Lawrie

19 Dec 2016 07:00

RNS Number : 2000S
Camellia PLC
19 December 2016
 

 

19 December 2016

 

Camellia Plc

 

Duncan Lawrie Private Bank ("Duncan Lawrie") - Update on Duncan Lawrie, sale of loan book and sale of Duncan Lawrie Asset Management

 

 

As highlighted in the recent interim report, lower interest rates and other factors have changed the outlook for private banking. This, coupled with its conservative risk appetite and opportunities for investment elsewhere in the group, has led Camellia Plc (the "Group") to review its earlier decision to invest further in Duncan Lawrie and it has therefore now decided to sell most of the Duncan Lawrie businesses.

The majority of Duncan Lawrie's UK loans and certain of its Isle of Man loans (the "Loan Book") have been sold to Arbuthnot Latham & Co. Limited for a cash consideration of £42.7 million, which equates to 95% of the value of the outstanding loans of £44.9 million. A subsequent orderly wind down of Duncan Lawrie's deposit taking and other banking operations in the UK and Isle of Man is proposed. Following this sale, Duncan Lawrie is fully funded to return all cash balances to clients.

Duncan Lawrie has also reached an agreement, subject to regulatory approval, to sell Duncan Lawrie Asset Management Limited to Brewin Dolphin Limited ("Brewin Dolphin"), a subsidiary of Brewin Dolphin Holdings Plc, for a cash consideration of £28.0 million.

Brewin Dolphin is one of the UK's leading discretionary wealth managers with over £35bn of funds under management and a long-term commitment to the market. As part of the transaction, the portfolio management team of Duncan Lawrie Asset Management Limited will move to Brewin Dolphin, providing continuity of service for clients and access to Brewin Dolphin's broader investment management and financial planning offering.

Camellia believes that both purchasers share the same high regard for client service as Duncan Lawrie and that in agreeing these sales, this should mitigate, as far as possible, the impact of these changes on clients and staff.

Discussions are underway with a number of other parties in respect of the sale of Duncan Lawrie's Isle of Man offshore trust services business.

The proceeds from these disposals will be used to repay depositors, meet any other liabilities of Duncan Lawrie and for investment in other parts of the Group.

The trading profits relating to the Loan Book in the year ending 31 December 2015 were £1.3 million and £0.8 million in the six months to 30 June 2016. The trading profits relating to Duncan Lawrie Asset Management in the year ending 31 December 2015 were £2.2 million and £0.6 million in the six months to 30 June 2016. These figures include costs which are not being transferred to the purchaser. The losses before taxation relating to the whole of Duncan Lawrie for the year ended 31 December 2015 were £3.6 million and £2.8 million in the six months to 30 June 2016.

The loss arising on sale of the Loan Book and significant closure costs of any proposed wind-down of Duncan Lawrie will be reflected in Camellia's financial results for the year ended 31 December 2016. The expected profit on disposal of Duncan Lawrie Asset Management and further operating costs relating to the proposed wind down will be reflected in Camellia's financial results for the year ended 31 December 2017.

Terms of the Loan Book sale

£34.7 million of the consideration is payable on completion today, with the balance of £8.0 million payable following novation or assignment of certain loan agreements which is expected to occur on 31 January 2017 ("Migration"). The consideration is subject to various adjustments on and shortly after Migration for loan repayments, advances and debt servicing costs in the period between 31 October 2016 and Migration.

Terms of the Duncan Lawrie Asset Management sale

Duncan Lawrie has agreed, subject to regulatory approval, to sell its wealth management business, Duncan Lawrie Asset Management Limited, but will retain the liabilities relating to the business, for £28.0 million payable at completion. The consideration is subject to a working capital adjustment.

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) N0. 596/2014

 

 

For further information:

 

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Fenchurch Advisory Partners LLP 020 7382 2222

Financial Adviser on the Duncan Lawrie Asset Management sale

Richard Locke

KPMG 020 7311 1000

Financial Adviser on the Loan Book sale

Andrew Jenke

Arun Sharma

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Andrew Godber

Erik Anderson

 

Maitland

William Clutterbuck 020 7379 5151

 

 

Fenchurch Advisory Partners LLP ("Fenchurch"), which is authorised and regulated by the FCA, is acting exclusively for Camellia plc and no-one else in connection with the sale of Duncan Lawrie Asset Management Limited and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Fenchurch nor for providing advice in relation to the sale of Duncan Lawrie Asset Management Limited or any other matters referred to in this announcement.

 

KPMG LLP, which is authorised and regulated in the UK by the FCA for investment business activities, is acting exclusively for Duncan Lawrie Holdings Limited (a subsidiary of Camellia plc) and no-one else in connection with the sale of the Loan Book and will not be responsible to anyone other than Duncan Lawrie Holdings Limited for providing the protections afforded to clients of KPMG LLP nor for providing advice in relation to the sale of the Loan Book or any other matters referred to in this announcement.

 

Panmure Gordon (UK) Limited is authorised and regulated in the United Kingdom by the FCA. Panmure Gordon (UK) Limited is acting as nominated adviser exclusively for Camellia plc and no one else in connection with the Disposals (as defined herein) and will not regard any other person as its client in relation to the Disposals and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Panmure Gordon (UK) Limited, nor for providing advice in relation to any matter referred to herein.

 

Forward looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the sale of the Loan Book and of Duncan Lawrie Asset Management Limited (the "Disposals"), and other information published by Camellia plc contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Camellia plc about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

The forward-looking statements contained in this announcement include statements relating to the expected effects of the Disposals on Camellia plc, the expected timing and scope of the Disposals and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although Camellia plc believes that the expectations reflected in such forward-looking statements are reasonable, Camellia plc can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. Neither Camellia plc nor any of its associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, Camellia plc is not under any obligation, and Camellia plc expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISQKLBFQLFZFBF
Date   Source Headline
30th Aug 20164:52 pmRNSHalf-year Report
25th Aug 201611:33 amRNSInterim Dividend 2016 - Record Date
25th Aug 20167:00 amRNSHalf-year Report
3rd Jun 20161:06 pmRNSResult of AGM
2nd Jun 201612:15 pmRNSAGM Statement
4th May 20161:12 pmRNSHolding(s) in Company
3rd May 20162:34 pmRNSAnnual Report and Notice of Annual General Meeting
29th Apr 20164:03 pmRNSDirector/PDMR Shareholding
28th Apr 20167:00 amRNSFinal Results
2nd Feb 20167:00 amRNSTrading Statement
12th Nov 201510:06 amRNSDirector/PDMR Shareholding
9th Nov 20157:00 amRNSSale of Loddon Engineering Limited
14th Sep 20152:08 pmRNSHalf Yearly Report
27th Aug 20157:00 amRNSHalf Yearly Report
27th Jul 20157:00 amRNSChange of Adviser
2nd Jul 20152:09 pmRNSBoard changes
5th Jun 201512:29 pmRNSResult of AGM
4th Jun 201511:30 amRNSAGM Statement
28th Apr 20153:45 pmRNSReport and Accounts
23rd Apr 20157:00 amRNSFinal Results
7th Apr 20152:43 pmRNSAKD Engineering Limited
2nd Apr 20151:44 pmRNSBoard changes
24th Nov 20149:19 amRNSDirectorate Change
2nd Oct 20143:02 pmRNSDirectorate Change
19th Sep 20149:11 amRNSAdmission to AIM
19th Sep 20148:00 amRNSCancellation - Camellia PLC
9th Sep 20142:00 pmRNSUpdate on Move to AIM
2nd Sep 201410:45 amRNSHalf Yearly Report
28th Aug 20147:00 amRNSHalf Yearly Report
20th Aug 20143:15 pmRNSSch 1 - Camellia Plc
20th Aug 20142:40 pmRNSUpdate on Move to AIM
14th Aug 20143:00 pmRNSCancellation of listing on Luxembourg Exchange
6th Aug 20142:30 pmRNSResult of AGM
6th Aug 201411:27 amRNSUpdate on Move to AIM
5th Aug 201410:16 amRNSTrading Update
11th Jul 20143:11 pmRNSShareholder Circular
11th Jul 20147:00 amRNSProposed Move to AIM
13th Jun 201411:16 amRNSNotification of Major Interest In Shares
10th Jun 20142:00 pmRNSDirectorate Change
6th Jun 201411:02 amRNSResult of AGM
5th Jun 201412:30 pmRNSAGM Statement
30th Apr 20142:26 pmRNSReport and Accounts
24th Apr 20144:13 pmRNSFinal Results - Replacement
24th Apr 20147:00 amRNSFinal Results
28th Mar 20143:16 pmRNSInterim Management Statement
3rd Mar 201411:35 amRNSTotal Voting Rights
3rd Feb 201412:32 pmRNSTotal Voting Rights
20th Jan 20144:38 pmRNSTransaction in Own Shares
9th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 20147:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.